 |
| Blockbuster News from BHRT and BICX Keeps National Expansion Rolling |
|
 Hot Stock to Watch
|
Company: Bioheart, Inc. (OTCQB: BHRT)
|
End of Day:
Price: 0.027
Change (%): - 0.0019 (6.57)
Volume: 275,036 |
 |
Bioheart Announces Clinical Trials in India
SUNRISE, FL-(Marketwired - Jul 7, 2014) - Bioheart, Inc. (OTCQB: BHRT) announced today that they have begun two clinical trials in India including the first ever combination stem cell trial in the world. The first cardiac patient has successfully been enrolled and treated in India using AdipoCell™ or adipose derived stem cells. The second trial will involve the combination of AdipoCell and MyoCell® or muscle derived stem cells for congestive heart failure patients. AdipoCell may help to promote angiogenesis or new blood vessel formation in ischemic tissue while MyoCell may help to promote myogenesis or new muscle formation.
Himanshu Bansal, MD, the study manager, said, “With India’s population and growing middle class the opportunities with Bioheart are limitless and we have many patients in India who can benefit from regenerative medicine and the Bioheart products. Conducting the first ever combination stem cell trial in the world will provide insights into future treatments.”
Continue Reading
|
 Yesterday's Top Performer
|
Company: BioCorRx Inc. (OTCQB: BICX)
|
End of Day:
Price: 0.1033
Change (%): + 0.0007 (0.68)
Volume: 15,823 |
 |
BioCorRx, Inc. Announces Distribution Rights in Ohio for Start Fresh Program
Los Angeles, July 1, 2014 (GLOBE NEWSWIRE) - BioCorRx, Inc. (OTCQB: BICX), a leader in addiction treatment and rehabilitation programs, announced it has closed another sale for the exclusive license and distribution rights of its Start Fresh Program to Sobriety and Addictions Solutions, LLC. Under the terms of the agreement, Sobriety and Addictions Solutions has paid BioCorRx, Inc. an upfront licensing fee and will also pay an upfront fee per program ordered in the state of Ohio. The closing of the Ohio territory marks the third transaction between Sobriety and Addictions Solutions, LLC and BioCorRx, Inc. The previous two transactions included the combined areas of Northern California, North Carolina, Maryland, Virginia, West Virginia, and Washington D.C.
The population of Ohio is just over 11.5 million people and the state is uniquely situated in that it is within only one day’s drive of 50% of all of North America’s population. Bringing the Start Fresh Program to Ohio gives hope not only to residents of the state, but to those within driving distance as well. Ohio recently saw a 24% increase in drunk driving deaths according to MADD and binge drinking rates in the state have been on a steady incline over the last decade.
Continue Reading |
Other Small Cap News
|
Company: Plandaí Biotechnology, Inc. (OTCQB: PLPL)
|
Plandai Biotechnology, Inc. Announces Support of ICCCO -- the World's First International Cannabis Trade Association
Association to Function as Independent Coalition of Organizations and Companies to Address Standards, Legislation and Trade Practices
SEATTLE, WA--(Marketwired - Jul 7, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced its support for the formation of the International Coalition of Cannabis Companies and Organizations (ICCCO), the world's first international cannabis trade association co-founded by Plandaí director, Jamen Shively. ICCCO was recently formed to deliver on the demands of citizens worldwide: the creation and maintenance of a global cannabis industry, which enforces social responsibility, generates jobs and tax revenues, and ensures consistent standards.
Continue Reading
|
Company: Advanced Medical Isotope Corporation (OTCQB: ADMD)
|
Battelle Acquires over 10% of Advanced Medical Isotope Corporation
KENNEWICK, Wash., July 7, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that Battelle, has acquired approximately 11% of AMIC's outstanding Common Stock. Battelle is a leading international science and technology enterprise that explores emerging areas of science and develops and commercializes technology.
In 2011, AMIC entered into license agreements with Battelle for 10 patents related to AMICs brachytherapy products; and in 2012, AMIC entered into an exclusive license agreement with Battelle for use of Battelle's patented brachytherapy gel technology.
Continue Reading |
Market News
|
By Lee Jackson: 24/7 Wall St
|
Key Stocks With Insiders Buying This Week
In what was a historic week for the stock markets, with all the big indexes hitting all-time highs, that didn’t stop insiders from stepping up to the plate to purchase more stock. For investors, aggressive insider buying at the top range of a secular bull market is just about the biggest confirmation that either good things are in the works earnings-wise, or something big could be a game-changing event for a company.
Insiders buying at market highs is huge, and it sends the message to investors that good things are still possible. While some add on a regular basis, others buy stock when they feel things are headed in the right direction. Either way, it is an extremely bullish sign - one our readers may want to take note of.
Continue Reading
|
By Patti Domm: CNBC
|
This will either make stock rally sizzle or snap
Despite the naysayers, earnings could put more sizzle into the stock market's bull run this summer.
In the week ahead, the first major reports of the second-quarter earnings season will begin to trickle out, with Alcoa on Tuesday and Wells Fargo on Friday.
"We've had very good gains, for the most part supported by earnings, or anticipated earnings growth," said Tobias Levkovich, chief U.S. equity strategist at Citigroup.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
